{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-002823","form_type":"8-K","ticker":"BRKR","cik":"0001109354","company_name":"BRUKER CORP","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.386391+00:00","generated_at":"2026-06-07T01:58:26.193180+00:00","sec_items":["2.02","7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bruker prelim Q4 rev >$830M, FY2023 >$2.94B; guides 2024 above-market organic growth","bullets":["Preliminary Q4 2023 revenue >$830M with organic growth >12% YoY; FY2023 revenue >$2.94B with organic growth >13% YoY.","BSI bookings reported as solid in Q4 2023.","2024 preliminary outlook: solid, above-market organic revenue growth and non-GAAP EPS.","Financial statements for Q4 and FY2023 not yet finalized or audited; subject to change."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-002823","json":"https://secwatch.observer/filing/0000950170-24-002823.json","markdown":"https://secwatch.observer/filing/0000950170-24-002823.md","text":"https://secwatch.observer/filing/0000950170-24-002823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1109354/000095017024002823/0000950170-24-002823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1109354/000095017024002823/brkr-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:58:26.193180+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ffa6675ef83f61bc7ce88cda67aeb25f6b00ebc","claim":"BRUKER CORP reported the full year 2023 results: revenue greater than $2.94 billion.","evidence_excerpt":"The Company also provided current preliminary expectation that revenue for the full year 2023 is greater than $2.94 billion, including organic revenue growth greater than 13% year-over-year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1109354/000095017024002823/0000950170-24-002823-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year 2023"},{"label":"Revenue","value":"greater than $2.94 billion"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"9bce6b6b571ff6d2b979785fa8db5254c77a552b","claim":"BRUKER CORP reported the fourth quarter of 2023 results: revenue greater than $830 million.","evidence_excerpt":"On January 8, 2024, during its scheduled presentation at the 42nd Annual J.P. Morgan Healthcare Conference, Bruker Corporation (the “Company”) stated that its current preliminary expectation for revenue for the fourth quarter of 2023 is greater than $830 million including organic revenue growth greater than 12% year-over-year and that fourth quarter 2023 BSI bookings were solid.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1109354/000095017024002823/0000950170-24-002823-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter of 2023"},{"label":"Revenue","value":"greater than $830 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}